Production of cytokines and metalloproteinases in rheumatoid synovitis is T cell dependent

Clinical Immunology

Volumn 90, Issue 1, 1999, Pages 65-78

  Klimiuk, Piotr A ^a   Yang, Hongyu ^a   Goronzy, Jörg J ^a   Weyand, Cornelia M ^a  

^a MAYO CLINIC   (United States)

Author keywords

CD4 T cells; Interferon TNF ; Pathogenesis; Rheumatoid arthritis

Indexed keywords

COLLAGENASE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 15; INTERLEUKIN 1BETA; METALLOPROTEINASE; TUMOR NECROSIS FACTOR ALPHA;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ARTICLE; CELL SURVIVAL; CELL TRANSFER; CHIMERA; CYTOKINE PRODUCTION; ENZYME SYNTHESIS; GENETIC TRANSCRIPTION; HELPER CELL; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SCID MOUSE; SYNOVIOCYTE; SYNOVITIS; SYNOVIUM;

EID: 0032951538     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.1998.4618     Document Type: Article

References (36)

1. Harris E. D. Rheumatoid Arthritis. 1997;Saunders, Philadelphia.
2. Weyand C. M., Goronzy J. J. Pathogenesis of rheumatoid arthritis. Med. Clin. North Am. 81:1997;29-55.
3. Panayi G. S., Lanchbury J. S., Kingsley G. H. The importance of the T cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis. Arthritis Rheum. 35:1992;729-735.
4. Winchester R. The molecular basis of susceptibility to rheumatoid arthritis. Adv. Immunol. 56:1994;389-466.
5. Nepom G. T., Nepom B. S. Prediction of susceptibility to rheumatoid arthritis by human leukocyte antigen genotyping. Rheum. Dis. Clin. North Am. 18:1992;785-792.
6. Weyand C. M., McCarthy T. G., Goronzy J. J. Correlation between disease phenotype and genetic heterogeneity in rheumatoid arthritis. J. Clin. Invest. 95:1995;2120-2126.
7. Van Boxel J. A., Paget S. A. Predominantly T-cell infiltrate in rheumatoid synovial membranes. N. Engl. J. Med. 293:1975;517-520.
8. Schroder A. E., Greiner A., Seyfert C., Berek C. Differentiation of B cells in the nonlymphoid tissue of the synovial membrane of patients with rheumatoid arthritis. Proc. Natl. Acad. Sci. USA. 93:1996;221-225.
9. Klimiuk P. A., Goronzy J. J., Bjornsson J., Beckenbaugh R. D., Weyand C. M. Tissue cytokine patterns distinguish variants of rheumatoid synovitis. Am. J. Pathol. 151:1997;1311-1319.
10. ++. J. Immunol. 1998.
11. Randen I., Brown D., Thompson K. M., Hughes-Jones N., Pascual V., Victor K., Capra J. D., Forre O., Natvig J. B. Clonally related IgM rheumatoid factors undergo affinity maturation in the rheumatoid synovial tissue. J. Immunol. 148:1992;3296-3301.
12. Rittner H. L., Zettl A., Jendro M. C., Bartz-Bazzanella P., Goronzy J. J., Weyand C. M. Multiple mechanisms support oligoclonal T cell expansion in rheumatoid synovitis. Mol. Med. 3:1997;452-465.
13. Ikeda Y., Masuko K., Nakai Y., Kato T., Hasanuma T., Yoshino S. I., Mizushima Y., Nishioka K., Yamamoto K. High frequencies of identical T cell clonotypes in synovial tissues of rheumatoid arthritis patients suggest the occurrence of common antigen-driven immune responses. Arthritis Rheum. 39:1996;446-453.
14. +--. J. Clin. Invest. 97:1996;2027-2037.
15. +-. J. Immunol. 161:1998;1018-1025.
16. Firestein G. S., Zvaifler N. J. How important are T cells in chronic rheumatoid synovitis? Arthritis Rheum. 33:1990;768-773.
17. Matteson E. L. Recent clinical trials in the rheumatic diseases. Curr. Opin. Rheumatol. 9:1997;95-101.
18. Feldmann M., Brennan F. M., Maini R. N. Rheumatoid arthritis. Cell. 85:1996;307-310.
19. Firestein G. S. Invasive fibroblast-like synoviocytes in rheumatoid arthritis. Passive responders or transformed aggressors? Arthritis Rheum. 39:1996;1781-1790.
20. Firestein G. S., Echeverri F., Yeo M., Zvaifler N. J., Green D. R. Somatic mutations in the p53 tumor suppressor gene in rheumatoid arthritis synovium. Proc. Natl. Acad. Sci. USA. 94:1997;10895-10900.
21. Ruderman E. M., Weinblatt M. E., Thurmond L. M., Pinkus G. S., Gravallese E. M. Synovial tissue response to treatment with Campath-1H. Arthritis Rheum. 38:1995;254-258.
22. Jendro M. C., Ganten T., Matteson E. L., Weyand C. M., Goronzy J. J. Emergence of oligoclonal T cell populations following therapeutic T cell depletion in rheumatoid arthritis. Arthritis Rheum. 38:1995;1242-1251.
23. Arnett F. C., Edworthy S. M., Bloch D. A., McShane D. J., Fries J. F., Cooper N. S., Healey L. A., Kaplan S. R., Liang M. H., Luthra H. S. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31:1988;315-324.
24. David C. S. Genes for MHC, TCR and MIs determine susceptibility to collagen induced arthritis. APMIS. 98:1990;575-584.
25. Buzas E. I., Brennan F. R., Mikecz K., Garzo M., Negroiu G., Hollo K., Cs-Szabo G., Pintye E., Glant T. T. A proteoglycan (aggrecan)-specific T cell hybridoma induces arthritis in BALB/c mice. J. Immunol. 155:1995;2679-2687.
26. Rendt K. E., Barry T. S., Jones D. M., Richter C. B., McCachren S. S., Haynes B. F. Engraftment of human synovium into severe combined immune deficient mice. Migration of human peripheral blood T cells to engrafted human synovium and to mouse lymph nodes. J. Immunol. 151:1993;7324-7336.
27. Kelsoe G. The germinal center: A crucible for lymphocyte selection. Semin. Immunol. 8:1996;179-184.
28. Zvaifler N. J., Tsai V., Alsalameh S., von Kempis J., Firestein G. S., Lotz M. Pannocytes: Distinctive cells found in rheumatoid arthritis articular cartilage erosions. Am. J. Pathol. 150:1997;1125-1138.
29. Wagner A. D., Bjornsson J., Bartley G. B., Goronzy J. J., Weyand C. M. Interferon-gamma-producing T cells in giant cell vasculitis represent a minority of tissue-infiltrating cells and are located distant from the site of pathology. Am. J. Pathol. 148:1996;1925-1933.
30. McInnes I. B., Leung B. P., Sturrock R. D., Field M., Liew F. Y. Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-alpha production in rheumatoid arthritis. Nat. Med. 3:1997;189-195.
31. McInnes I. B., al-Mughales J., Field M., Leung B. P., Huang F. P., Dixon R., Sturrock R. D., Wilkinson P. C., Liew F. Y. The role of interleukin-15 in T-cell migration and activation in rheumatoid arthritis. Nat. Med. 2:1996;175-182.
32. Elliott M. J., Maini R. N., Feldmann M., Long-Fox A., Charles P., Bijl H., Woody J. N. Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis. Lancet. 344:1994;1125-1127.
33. Elliott M. J., Maini R. N., Feldmann M., Kalden J. R., Antoni C., Smolen J. S., Leeb B., Breedveld F. C., Macfarlane J. D., Bijl H. Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis. Lancet. 344:1994;1105-1110.
34. Moreland L. W., Baumgartner S. W., Schiff M. H., Tindall E. A., Fleischmann R. M., Weaver A. L., Ettlinger R. E., Cohen S., Koopman W. J., Mohler K., Widmer M. B., Blosch C. M. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. N. Engl. J. Med. 337:1997;141-147.
35. Arend W. P., Dayer J. M. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis. Arthritis Rheum. 38:1995;151-160.
36. Williams R. O., Mason L. J., Feldmann M., Maini R. N. Synergy between anti-CD4 and anti-tumor necrosis factor in the amelioration of established collagen-induced arthritis. Proc. Natl. Acad. Sci. USA. 91:1994;2762-2766.